| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.8 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |